Litcius/Paper detail

Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients

L Boekel, G J Wolbink

2021The Lancet Rheumatology34 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRituximabIntensive care medicineInternal medicineMEDLINEClinical trialOncologyAntibody therapyDiseasePediatricsSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders